The global demand for extraction kits is expected to increase at 7.1% CAGR over the forecast period. The extraction kits market size is estimated to reach a valuation of USD 1,293.4 million by 2023. According to the study, DNA extraction kit products held a substantial share of 49.88% in 2022 in the global market.
Salient Factors Catalyzing the Market Growth Include:
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
An increasing number of research and development activities to develop vaccines to combat the diseases is expected to boost the market. Hence, key players are investing extensively to gain a competitive edge in the industry.
Other initiatives, such as the EMBO, and Young Investigator Program aids in the establishment of laboratories by life scientists. Under this initiative, the young researchers are expected to receive funding for four years. This is going to help them to establish their networking and training, enhancing their research development.
All research initiatives are projected to help the key players in the market to expand their footprints in emerging economies. Such situations are expected to help create attractive opportunities for local players to strengthen their position and increase their market share over the forecast period.
Key Factors Restraining the Extraction Kits Demand
| Data Points | Market Insights |
|---|---|
| Extraction Kits Industry Value 2022 | USD 1,218.4 million |
| Extraction Kits Market Value 2023 | USD 1,293.4 million |
| Extraction Kits Market Value 2033 | USD 2,556.6 million |
| Extraction Kits Industry CAGR 2023 to 2033 | 7.1% |
| Market Share of Top 5 Countries | 56.5% |
According to Future Market Insights (FMI), the overall sales of extraction kits expanded at a CAGR of 7.4% between 2018 and 2022. However, the demand in the extraction kits industry is expected to increase at a CAGR of 7.1%, surpassing USD 2,556.6 million by the end of 2033.
The global extraction kits market held around 5.0% of the global genome sequencing market, which was valued at nearly USD 23 billion in the year 2021.
Market expansion is underpinned by growing innovation in molecular diagnostic techniques, resulting in the detection of numerous diseases. Integration of automation in these extraction systems is projected to simplify and improve the yield of nucleic acid extraction.
For instance, Indian start-up 30M Genomics has developed a new extraction kit called AmpReady for extracting DNA from biological samples in five seconds without requiring any equipment. These kits offer accuracy and higher efficiency in analysis.
With a slew of advancements in automation for nucleic acid extraction, the market is projected to witness impressive growth over the coming years.
Rising investment by government bodies and other organizations for research and development activities in molecular diagnostics is likely to fuel the market. Increased funding for life science research and investments in molecular diagnostics is projected to fuel market growth.
According to UNESCO’s data, Germany spent about USD 4 billion in 2021 to promote and boost research and development activities in the country. In China, the National Bureau of Statistics stated that China spent almost USD 440.0 billion on research and development in 2021.
As per the study, there was a 40% rise in spending as compared to 2020. As research and development funding activities are increasing across the globe, the extraction kits industry is poised to expand at a steady rate.
Based on product, DNA extraction kits were the dominant market segment in the global market in 2022, which contributed 49.88% of the revenue share. The global extraction kits market is expected to be valued at USD 2,556.6 million by the end of 2033, registering a CAGR of 7.1% in the forecast period.
Principal Consultant
| Region | North America |
|---|---|
| Market Share % 2022 | 33.4% |
| Market Size (USD million) by 2023 | USD 431.99 million |
| Market Size (USD million) by End of Forecast Period (2033) | USD 853.90 million |
North America region held a market share of 33.4% in 2022. The market growth has been underpinned by several research and development activities. In addition to this, industry players are consistently updating their product portfolios, which is assessed to positively influence market trajectory. Other factors stimulating regional growth include:
| Region | Europe |
|---|---|
| Market Share % 2022 | 28.7% |
| Market Size (USD million) by 2023 | USD 371.2 million |
| Market Size (USD million) by End of Forecast Period (2033) | USD 733.74 million |
In 2022, Europe acquired a 28.7% market share in the global landscape. In the same year, the region gained USD 371.2 million, and by 2033, the market is projected to gain USD 733.74 million.
The large contribution of Europe in the global sphere is due to the accelerating patient population and beneficial government initiatives. Take for example, in 2020, Merck invested USD 21.09 million to create a life sciences lab in Switzerland, Europe.
This is projected to expedite and encourage research and development activities for the company, in addition to quality control and analytical production.
| Country | The United States |
|---|---|
| Market Share % 2022 | 31% |
| Market Size (USD million) by 2023 | USD 400.95 million |
| Market Size (USD million) by End of Forecast Period (2033) | USD 792.54 million |
According to Future Market Insights, the United States is expected to dominate North America, with a total market share of 92.8% in 2022. The country is projected to continue to exhibit high growth through 2023 and beyond.
In the global landscape, the United States’ share in the market stood maximum at 31% in 2022. In 2023, the market is assessed to amass a total of USD 400.95 million. Similarly, by the forecast period’s end, the market is estimated to be valued at a maximum of USD 792.54 million.
Technological advancements in the automation of DNA & RNA extraction across the United States is projected to drive product demand. For instance, Thermo Fischer Scientific launched the Thermo Scientific KingFisher Apex Purification System in April 2021.
| Country | Germany |
|---|---|
| Market Share % 2022 | 7.3% |
| Market Size (USD million) by 2023 | USD 94.41 million |
| Market Size (USD million) by End of Forecast Period (2033) | USD 186.63 million |
Germany is set to exhibit growth at a CAGR of 8.3% in Europe’s extraction kits market during the forecast period. Germany’s market captured 7.3% of the global market in 2022. By the end of the assessment period, the market is projected to be valued at a sum of USD 186.63 million.
Increasing investment in research and development in Germany is uplifting the regional market status. Also, the development of new technologies for the fast detection of clinically important compounds is projected to facilitate market expansion.
| Country | China |
|---|---|
| Market CAGR % through till 2033 | 9.8% |
China is projected to expand at a CAGR rate of 9.8% during the forecast period, anticipating Future Market Insights (FMI). China is expected to spearhead the growth in East Asia due to technological advancement in the healthcare sector.
Key players in the country are working toward developing sophisticated automated systems for nucleic acid extraction. Consequently, augmenting the product’s demand in the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | DNA Extraction Kits |
|---|---|
| Market Share (2022) | 49.88% |
| Market Size (2023) | USD 645.14 million |
| Market Size (2033) | USD 1,275.23 million |
The DNA extraction kits contributed about 49.88% of the market share in 2022 and are expected to register a CAGR of 7.4% in the forecast period. The availability of a wide range of robust kits and ease of application in various molecular biology applications for the detection of nucleic acids in cancerous tissues is projected to aid segment growth.
Nearly 2 out of 5 Extraction Kits Sales Come from Disease Diagnosis
| Segment | Disease Diagnosis |
|---|---|
| Market Share (2022) | 37.08% |
| Market Size (2023) | USD 479.59 million |
| Market Size (2033) | USD 947.98 million |
In terms of application, the disease diagnosis segment is expected to hold a 37.08% share in revenue, exhibiting growth at 7.8% CAGR in the forecast period. The increasing prevalence of chronic diseases, genetic disorders, and cancer has led to an increase in the use of DNA & RNA extraction kits. This is projected to contribute to the market expansion in the forecast period.
Burgeoning Need for Nucleic Acid Extraction Kits in Diagnostic Laboratories to Propel the Sales
Based on end users, the diagnostic laboratories segment held a market share of more than 29.9% in 2022 and is poised to expand at a CAGR of 7.9% over the upcoming decade.
Demand for extraction kits in diagnostic laboratories is increasing due to the high adoption of nucleic acid extraction kits for identifying and characterizing microbes. These microbes are the prime cause of certain chronic ailments.
Key Developments in the Extraction Kits Market:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | The United States, Canada, Brazil, Mexico, Argentina, Germany, the United Kingdom, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, North Africa, GCC Countries, Türkiye, and South Africa |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Bio Rad Laboratories Inc.; Thermo Fisher Scientific; Promega Corporation; Agilent Technologies; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; Qiagen; General Biosystems; Takara Bio Inc.; Roche Life Science; GeneReach Biotechnology Corporation.; Merck Millipore; BioFire Defense LLC; Akonni Biosystems, Inc; Primerdesign Ltd. |
| Pricing | Available upon Request |
The market is estimated to secure a valuation of USD 1,293.4 million in 2023.
The market is estimated to reach USD 2,556.6 million by 2033.
Through 2033, the market is anticipated to expand at a 7.1% CAGR.
Enhancing government financing for the advancement of extraction technologies to establish new growth potential.
The United States has a substantial market share at 31%.
The DNA extraction kits accounted for about 49.88% of the market share.
The disease diagnosis category is set to rise at a 7.8% CAGR.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. DNA Extraction Kits 5.1.1. Sequence-specific DNA 5.1.2. Cell-free DNA (cfDNA) 5.1.3. Tissue DNA Extraction Kits 5.2. RNA Extraction Kits 5.2.1. Total RNA 5.2.2. Purified RNAs 5.2.3. Viral RNA 5.2.4. Sequence-specific RNA 5.3. Total nucleic acid (RNA + DNA) 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Disease Diagnosis 6.2. Drug Discovery 6.3. Cancer Research 6.4. cDNA Library 6.5. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Hospitals 7.2. Academic and Research Institutions 7.3. Pharmaceutical and Biotechnology Companies 7.4. Clinical Research Organisations 7.5. Diagnostic Laboratories 7.6. Forensic Labs 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. Asia Pacific 8.5. MEA 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Key Countries Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. Bio Rad Laboratories Inc. 16.2. Thermo Fisher Scientific 16.3. Promega Corporation 16.4. Agilent Technologies 16.5. Bioneer Corporation 16.6. PerkinElmer Inc. 16.7. LGC Biosearch Technologies 16.8. Qiagen 16.9. General Biosystems 16.10. Takara Bio Inc. 16.11. Roche Life Science 16.12. GeneReach Biotechnology Corporation. 16.13. Merck Millipore 16.14. BioFire Defense LLC 16.15. Akonni Biosystems, Inc. 16.16. Primerdesign Ltd. 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Extraction Kits Market
